Cancer research, Leukemia, Myeloid leukemia, Molecular biology and Genetics are her primary areas of study. The concepts of her Cancer research study are interwoven with issues in Haematopoiesis, Stem cell, microRNA, Lymphoma and Myeloid-Lymphoid Leukemia Protein. The Leukemia study combines topics in areas such as Myeloid and Pathology.
Her study in Myeloid leukemia is interdisciplinary in nature, drawing from both Progenitor cell, Chromosome 7, Genetic testing and Gene expression profiling. Her Molecular biology study combines topics in areas such as Fluorescence in situ hybridization, Prostate, Proto-oncogene tyrosine-protein kinase Src and Cell cycle checkpoint. Her Acute leukemia research is multidisciplinary, incorporating perspectives in Myeloproliferative neoplasm, Acute erythroid leukemia, Atypical chronic myeloid leukemia and Intensive care medicine.
Michelle M. Le Beau mainly focuses on Cancer research, Genetics, Molecular biology, Leukemia and Myeloid leukemia. Her study on Cancer research also encompasses disciplines like
Her Leukemia research integrates issues from Myeloid, Trisomy and Chromosomal translocation. Her Myeloid leukemia course of study focuses on Oncology and Disease. She specializes in Immunology, namely Acute leukemia.
Michelle M. Le Beau focuses on Cancer research, Myeloid, Myeloid leukemia, Leukemia and Immunology. Her Cancer research research is multidisciplinary, incorporating elements of Haematopoiesis, Carcinogenesis, microRNA, Regulation of gene expression and Bone marrow. Her studies in Myeloid leukemia integrate themes in fields like SOX4, Molecular biology, NPM1, Promyelocytic leukemia protein and RUNX1T1.
Leukemia is a subfield of Internal medicine that Michelle M. Le Beau explores. Her biological study spans a wide range of topics, including Cancer, Anemia, Overall survival, Prognostic classification and Risk stratification. Her Myelodysplastic syndromes study deals with Intensive care medicine intersecting with Acute leukemia, Myeloproliferative neoplasm, Acute erythroid leukemia and Atypical chronic myeloid leukemia.
Her primary areas of study are Myeloid leukemia, Leukemia, Immunology, Cancer research and Myeloid. Her Myeloid leukemia study incorporates themes from Mutation, Haploinsufficiency, International working group and Gerontology. The various areas that Michelle M. Le Beau examines in her Leukemia study include Molecular biology, Cancer, Bone marrow and Downregulation and upregulation.
Her Immunology study integrates concerns from other disciplines, such as Internal medicine and Oncology. Her studies in Cancer research integrate themes in fields like Insertional mutagenesis, Haematopoiesis, Carcinogenesis, microRNA and Locus. The various areas that Michelle M. Le Beau examines in her Myelodysplastic syndromes study include Myeloid Neoplasm, Myeloproliferative neoplasm, Intensive care medicine and Acute leukemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele.
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning.
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael.
The New England Journal of Medicine (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg;Heinz Tuechler;Julie Schanz;Guillermo Sanz.
The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.
James P Carney;James P Carney;Richard S Maser;Heidi Olivares;Elizabeth M Davis.
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan;Christopher B. Miller;Ina Radtke;Letha A. Phillips.
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
Robert E. Reiter;Zhennen Gu;Tetsuro Watabe;George Thomas.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Joshua Wechsler;Marianne Greene;Michael A. McDevitt;John Anastasi.
Nature Genetics (2002)
Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development.
Steven T. Kosak;Jane A. Skok;Kay L. Medina;Roy Riblet.
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Omar Abdel-Wahab;Ann Mullally;Cyrus Hedvat;Guillermo Garcia-Manero.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: